실시간

CellExpansion and CAR engineering of granulocyte-monocyte progenitors for cellular immunotherapy Endpoints NewsBiopharma’s LGBTQ+ leaders; Novo Nordisk hacked?; and more Science Daily BiotechThe secret language behind animal cooperation Endpoints NewsEndpoints News History: 10 Years, Bootstrap to FT Clinical OMICsImproving HSV-2 Vaccine Efficacy with Combination Strategy CellMultimodal imaging of gene expression, morphology, and activity of the same neuron 10x Genomics News10x Genomics, Cleveland Clinic Team Up on Bladder Cancer Diagnostics - Zacks Investment Research FierceBiotechFDA warning slams Zoll Medical with multiple quality control and reporting violations BioWorldHangzhou Innogate Pharma discovers new KAT inhibitors BioWorldAlicorn synthesizes new AAK1 inhibitors BioWorldChinese scientists identify new macrocyclic compounds as kinase inhibitors BioWorldNew VAV1 degradation inducers reported in Haisco Pharmaceutical Group patents

아카이브

최신 오래된 순 지우기

전체 62

페이지 3 / 4

검색어 --

Endpoints News 2026년 3월 24일

Merck partners with Flagship startup Quotient to search for genetic clues to IBD

BioWorld 2026년 3월 6일

Cas and effect: Merck’s phase III ripples HIF-2α space

FierceBiotech 2026년 3월 6일

Merck KGaA drops pipeline assets from SpringWorks buyout, Hengrui licensing deal

Endpoints News 2026년 3월 5일

Merck KGaA drops two cancer trials on assets from SpringWorks deal

Merck KGaA 2026년 3월 5일

Merck KGaA drops pipeline assets from SpringWorks buyout, Hengrui licensing deal - Fierce Biotech

BioWorld 2026년 2월 26일

MSD patent details new WRN inhibitors for cancer

Endpoints News 2026년 2월 25일

Gilead, Merck plan to debut new daily HIV pills

Endpoints News 2026년 2월 23일

Merck reorganizes; Blackstone to fund trials for J&J drug

BioPharma Dive 2026년 2월 23일

Merck to split cancer, specialty drug businesses in leadership shakeup

PharmaVoice 2026년 2월 20일

No one-trick pony in oncology, Merck’s cancer footprint is expanding

Endpoints News 2026년 2월 19일

Biogen stops part of an MS trial; Merck reports more Enflonsia data

BioPharma Dive 2026년 2월 12일

Sanofi, looking for more ‘rigor,’ swaps CEO Hudson for ex-Merck KGaA chief Garijo

FierceBiotech 2026년 2월 12일

Sanofi ousts Paul Hudson after ‘bumpy ride’, poaches Merck KGaA CEO to lead the French pharma

FierceBiotech 2026년 2월 10일

Merck teams up with British medtech to boost vaginal therapeutics delivery system

BioPharma Dive 2026년 1월 13일

JPM26: Biotech’s M&A lift, the ‘new’ Biogen and Merck’s $70B target

Endpoints News 2026년 1월 12일

FDA lifts partial hold on Merck, Daiichi's Phase 3 lung cancer study

BioPharma Dive 2026년 1월 12일

Eikon, a high-profile startup led by Merck vets, seeks an IPO

Endpoints News 2026년 1월 9일

How Merck plans to set a buffer for Keytruda's patent cliff